, Tracking Stock Market Picks
Enter Symbol:
Henry Schein, Inc. (HSIC) [hlAlert]

up 129.86 %

Henry Schein, Inc. (HSIC) rated Outperform with price target $80 by Barrington Research

Posted on: Tuesday,  May 3, 2011  3:25 PM ET by Barrington Research

Barrington Research rated Outperform Henry Schein, Inc. (NASDAQ: HSIC) on 05/03/2011. Previously Barrington Research rated Outperform Henry Schein, Inc. (NASDAQ: HSIC) on
04/14/2010., when the stock price was $60.33. Since then, Henry Schein, Inc. has gained 129.87% as of 01/27/2016's recent price of $138.68.
If you would have followed the previous Barrington Research's recommendation on HSIC, you would have gained 129.86% of your investment in 2114 days.

Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. The company conducts its business principally through two segments; healthcare distribution and technology. These segments, which are operated as individual business units, offer different products and services, albeit to the same customer base. The healthcare distribution segment consists of the company's dental, medical, veterinary and international groups.

As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in providing value to our clients. Our research provides us with a comprehensive understanding of the economy, financial markets, and individual companies, all of which are essential in recommending successful investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/3/2011 3:25 PM Buy
73.27 80.00
as of 12/30/2011
1 Week down  -1.07 %
1 Month up  0.13 %
3 Months up  3.90 %
1 YTD up  4.95 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/14/2010 8:25 AM Buy
60.33 74.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy